EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Historical Perspective and Update on Robotic Mitral Valve Surgery

Amy Chartrain iD, Alfredo Trento, George Gill, Dominic Emerson, Wen Cheng iD, Danny Ramzy, Joanna Chikwe

Journal of Clinical Medicine · 24.10.2024 · 13 (21) · 6375

DOI: 10.3390/jcm13216375 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 24.10.2024. Verfasst von Amy Chartrain und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Minimally invasive techniques for mitral valve repair have evolved over the past thirty years and include mini-thoracotomies and the robotic platform. This study provides a historical perspective on minimally invasive mitral valve approaches and evaluates long-term outcomes of a large series of robotic mitral valve repairs.

Methods

A single-institution, prospectively maintained registry was used to evaluate robotic mitral valve repairs performed by four surgeons from 2005 to 2023. There were 1412 robotic mitral valve repairs performed during this time and stratified by the first 120 and subsequent patients. We evaluated operative outcomes and freedom from more than 2+ mitral regurgitation at five years as well as ten-year survival.

Results

Of the 1412 robotic mitral valve repairs performed, 93.6% (n = 1322) were for degenerative disease. Compared to the first 120 patients, the subsequent patients had a significant reduction in cross-clamp time (112 (IQR = 103–130) versus 75 (IQR = 65–88) min) and cardiopulmonary bypass time (153.5 (IQR = 134.5–177.5) versus 116 (IQR = 103–136) min), and all with p < 0.01. The majority of patients had posterior leaflet prolapse (65.6%, n = 926). The repair rate was 98.1%, n = 1385. Survival at ten-year follow-up for the patients included in the first 120 procedures was 91.5% (95% confidence interval (CI) = 86.4–96.6%) versus 92.8% (95% CI = 91.7–93.9%) for the patients who were in the latter group, p = 0.58. Freedom from >2+ mitral regurgitation at 5 years was 97.0% (95% CI = 95.3–98.7%) for the patients in the first 120 procedures and 92.7% (95% CI = 91.5–93.9%), p = 0.22, for those in the latter group.

Conclusions

The robotic platform offers an excellent durable repair for mitral regurgitation in our experience of over 1400 patients. The robotic platform for mitral valve repair offers a teachable and safe approach to mitral valve disease for patients.

Schlagwörter

Stichwörter der Autor:innen

minimally invasive cardiac surgeryrobotic mitral valve repairrobotic surgery

Autor:innen und Institutionen

  • Department of Cardiac Surgery, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
  • Department of Cardiac Surgery, UTHealth Houston, Houston, TX 77030, USA.

ORCID-Profile: Amy Chartrain, Wen Cheng

Zitieren

APA

Chartrain, A., Trento, A., Gill, G., Emerson, D., Cheng, W., Ramzy, D., & Chikwe, J. (2024). A Historical Perspective and Update on Robotic Mitral Valve Surgery. Journal of Clinical Medicine, 13(21), 6375. https://doi.org/10.3390/jcm13216375

Vancouver

Chartrain A, Trento A, Gill G, Emerson D, Cheng W, Ramzy D, et al. A Historical Perspective and Update on Robotic Mitral Valve Surgery. Journal of Clinical Medicine. 2024;13(21):6375. doi:10.3390/jcm13216375

BibTeX
@article{Chartrain2024,
  author = {Chartrain, Amy and Trento, Alfredo and Gill, George and Emerson, Dominic and Cheng, Wen and Ramzy, Danny and Chikwe, Joanna},
  title = {A Historical Perspective and Update on Robotic Mitral Valve Surgery},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {21},
  pages = {6375},
  doi = {10.3390/jcm13216375}
}
Kostenlos starten →